Skip to content

IGC PHARMA, INC.: 10-Q filed 2011-11-18

What IGC PHARMA, INC. reported in its quarterly report filed 2011-11-18 (fiscal Q2 2011): 41 published measures, 104 facts as tagged in accession 0001185185-11-002076.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-18
Fiscal period
fiscal Q2 2011
Accession
0001185185-11-002076 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IGC PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-3016,093,740USD
At 2011-03-3118,162,069USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-306,715,393USD
At 2011-03-317,786,826USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-305,680,831USD
At 2011-03-316,666,306USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-30766,829USD
At 2011-03-311,583,284USD
At 2010-09-30388,178USD
At 2010-03-31842,923USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-789,253USD92
2011-04-01 to 2011-09-30-1,658,455USD183
2010-04-01 to 2011-03-31-20,240,907USD365
2010-07-01 to 2010-09-30-856,260USD92
2010-04-01 to 2010-09-30-1,447,434USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-04-01 to 2011-09-30-813,813USD183
2010-04-01 to 2010-09-30-1,811,219USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-07-01 to 2011-09-30912,121USD92
2011-04-01 to 2011-09-301,972,368USD183
2010-07-01 to 2010-09-301,681,586USD92
2010-04-01 to 2010-09-302,809,997USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2010-04-01 to 2010-09-301,185,669USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-04-01 to 2011-09-3038,349USD183
2010-04-01 to 2010-09-30166,406USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-31,351,362USD
At 2011-03-31-29,692,907USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-07-01 to 2011-09-3020,960,433shares92
2011-04-01 to 2011-09-3020,699,660shares183
2010-07-01 to 2010-09-3013,427,020shares92
2010-04-01 to 2010-09-3013,343,949shares183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-07-01 to 2011-09-3020,960,433shares92
2011-04-01 to 2011-09-3020,699,660shares183
2010-07-01 to 2010-09-3013,427,020shares92
2010-04-01 to 2010-09-3013,343,949shares183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-0.04USD/shares92
2011-04-01 to 2011-09-30-0.08USD/shares183
2010-07-01 to 2010-09-30-0.06USD/shares92
2010-04-01 to 2010-09-30-0.11USD/shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-0.04USD/shares92
2011-04-01 to 2011-09-30-0.08USD/shares183
2010-07-01 to 2010-09-30-0.06USD/shares92
2010-04-01 to 2010-09-30-0.11USD/shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2010-07-01 to 2010-09-30-33,331USD92
2010-04-01 to 2010-09-30-455,014USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-30996,704USD
At 2011-03-311,231,761USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-04-01 to 2011-09-30235,267USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-719,398USD92
2011-04-01 to 2011-09-30-1,417,844USD183
2010-07-01 to 2010-09-30-795,810USD92
2010-04-01 to 2010-09-30-1,328,119USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-305,779,851USD
At 2011-03-316,545,164USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-07-01 to 2011-09-30148,965USD92
2011-04-01 to 2011-09-30449,733USD183
2010-07-01 to 2010-09-30197,611USD92
2010-04-01 to 2010-09-30410,709USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-305,984,797USD
At 2011-03-316,577,347USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-09-301,174,104USD
At 2011-03-311,311,963USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-09-30334,723USD
At 2011-03-31410,454USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-302,381,247USD
At 2011-03-313,312,051USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-09-30103,729USD
At 2011-03-31133,539USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2011-07-01 to 2011-09-30903,523USD92
2011-04-01 to 2011-09-301,877,832USD183
2010-07-01 to 2010-09-301,612,753USD92
2010-04-01 to 2010-09-302,596,133USD183

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-07-01 to 2011-09-30652,375USD92
2011-04-01 to 2011-09-301,385,515USD183
2010-07-01 to 2010-09-30763,713USD92
2010-04-01 to 2010-09-301,344,609USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-3016,091,843shares
At 2011-03-3114,890,181shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-3039,677,590USD
At 2011-03-3138,860,319USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-09-30-2,647,007USD
At 2011-03-31-2,502,596USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-09-306,295,963USD
At 2011-03-317,292,859USD
At 2010-03-3126,153,460USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-09-30145,716USD
At 2011-03-31748,623USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-09-30730,596USD
At 2011-03-311,209,479USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-09-30390,344USD
At 2011-03-31349,149USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-302,486,594USD
At 2011-03-311,474,838USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-798,216USD92
2011-04-01 to 2011-09-30-1,669,169USD183
2010-07-01 to 2010-09-30-858,783USD92
2010-04-01 to 2010-09-30-1,449,997USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-04-01 to 2011-09-30126,865USD183
2010-04-01 to 2010-09-30197,374USD183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2010-04-01 to 2010-09-30-456,920USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-04-01 to 2010-09-301,444,152USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-09-30656,451USD183
2010-04-01 to 2010-09-30-1,180,490USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-09-3018,376USD183
2010-04-01 to 2010-09-30-49,157USD183

Inspect the source

Entity
IGC PHARMA, INC. / CIK 0001326205
Captured
2026-09-19T11:17:33.392Z
SEC response SHA-256
b5e6159ba110e204ee8261b531c546158153a9053fcdb3ca873d1eff8c2a793e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))